Latest filing published 14 Dec 2023 for Bluejay Diagnostics, Inc., €1,421.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Svetlana Dey: trading record in brief
Svetlana Dey, listed as board member, appears in our data through filings on Bluejay Diagnostics, Inc. shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 17 March 2022 and the latest from 13 December 2023.
The open-market record is one-sided, with 3 purchases worth €16k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants. In 2023 alone, the filings show 2 purchases and no sales.
Half of the purchases are above €4,061 and half below.
The record was last updated on 14 December 2023 with an open-market purchase (€1,421) in Bluejay Diagnostics, Inc. Filings reach the SEC (Form 4) feed a median of 6 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Svetlana Dey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500 shares@ US$3.074.5% of flowCommon StockSEC:0001062993-23-022569:0Canonical exit: 12 Mar 2024 (T+90)
- 10,000 shares@ US$0.4412.9% of flowCommon StockSEC:0001213900-23-025245:0Canonical exit: 22 Jun 2023 (T+90)
- 10,000 shares@ US$0.4412.9% of flowCommon StockSEC:0001213900-23-022724:0
- 27,500 shares@ US$0.4435.5% of flowCommon StockSEC:0001213900-23-010887:0
- 10,000 shares@ US$1.18339.2% of flowCommon StockSEC:0001213900-22-013761:0Canonical exit: 15 Jun 2022 (T+90)
5 of 5 declarations